Canakinumab Subcutaneous and Metoprolol and Hydrochlorothiazide Extended-Release Tablets
Determining the interaction of Canakinumab Subcutaneous and Metoprolol and Hydrochlorothiazide Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: canakinumab
Brand name: Ilaris
Synonyms: Canakinumab
Generic Name: hydrochlorothiazide / metoprolol
Brand name: Dutoprol, Lopressor HCT
Synonyms: Hydrochlorothiazide and metoprolol, Metoprolol and Hydrochlorothiazide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Canakinumab Subcutaneous-Metoprolol and Hydrochlorothiazide Tablets
- Canakinumab Subcutaneous-Metoprolol Extended-Release Capsules
- Canakinumab Subcutaneous-Metoprolol Extended-Release Tablets
- Canakinumab Subcutaneous-Metoprolol Injection
- Canakinumab Subcutaneous-Metoprolol Intravenous
- Canakinumab Subcutaneous-Metoprolol Succinate
- Metoprolol and Hydrochlorothiazide Extended-Release Tablets-Canasa
- Metoprolol and Hydrochlorothiazide Extended-Release Tablets-Canasa Pac rectal
- Metoprolol and Hydrochlorothiazide Extended-Release Tablets-Canasa rectal
- Metoprolol and Hydrochlorothiazide Extended-Release Tablets-Cancidas
- Metoprolol and Hydrochlorothiazide Extended-Release Tablets-Candesartan
- Metoprolol and Hydrochlorothiazide Extended-Release Tablets-Candesartan and Hydrochlorothiazide